Peer-reviewed veterinary case report
A retrospective study of treatment, outcome, recurrence and concurrent diseases in 190 dogs with anal sacculitis.
- Journal:
- Veterinary dermatology
- Year:
- 2023
- Authors:
- Hvitman-Graflund, Katinka et al.
- Affiliation:
- AniCura Aros VeterinarCentrum AB
- Species:
- dog
Plain-English summary
This study looked at 190 dogs in Sweden that were diagnosed with anal sacculitis, which is an inflammation of the glands near their rear end. The most common treatment involved flushing the glands and giving a pain-relieving medication, which worked well for about 90% of the cases. Most dogs got better within a week, although some took longer. It was noted that dogs with skin allergies were more likely to have repeat episodes of anal sacculitis compared to those with other health issues. Overall, the treatment was effective for most dogs, but those with skin allergies might need extra attention to prevent future problems.
Abstract
BACKGROUND: Few studies report the treatment and recurrence rate in anal sacculitis (AS). OBJECTIVES: Retrospective study reporting the management, recurrence and concurrent diseases in dogs with AS in a primary care practice. ANIMALS: One hundred and ninety privately owned dogs in Sweden. MATERIALS AND METHODS: Clinical records of dogs diagnosed with AS between 2018 and 2021 were reviewed, and management, time until clinical resolution, number of recurrent episodes and comorbidites were recorded. RESULTS: The 190 dogs developed 290 episodes of AS. The most common management, in 235 of 290 (81.0%) episodes, was flushing ± infusion of an antimicrobial product into the sacs ± prescription of a nonsteroidal anti-inflammatory drug (NSAID), providing resolution in 213 of 235 (90.6%) episodes. Median time to resolution was one week (range 1-16 weeks), with resolution seen within one week in 205 of 290 (70.7%) episodes. A single episode of AS developed in 126 of 190 (66.3%) dogs. Dogs with concurrent cutaneous allergic disease were more likely (p < 0.001) to have recurrence of AS when compared to dogs with other comorbidities. Cutaneous allergic disease occurred more often (p < 0.001) in dogs with AS than in the practice population. CONCLUSIONS AND CLINICAL RELEVANCE: Local treatment of the anal sacs ± systemic NSAID was the most common treatment, inducing clinical resolution in the majority of dogs. Cutaneous allergic disease was the most common concurrent diagnosis, with higher recurrence rate of AS compared to other diseases and occurring in higher prevalence than in the practice population. Further studies are needed to determine if management of cutaneous allergic disease would reduce the risk of AS.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/37731183/